Prot #233AS101: A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB067 Administered to Adult Subjects with Amyotrophic Lateral Sclerosis and Confirmed Superoxide Dismutase 1 Mutation

Project: Research project

Project Details

StatusFinished
Effective start/end date9/9/20 → 9/9/23

Funding

  • Quintiles, Inc. (Prot#233AS101 // Prot#233AS101)
  • Biogen MA Inc. (Prot#233AS101 // Prot#233AS101)